Zhang J, Peng P, Li X, Zha Y F, Xiang Y, Zhang G N, Zhang Y
Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhonghua Fu Chan Ke Za Zhi. 2020 Apr 25;55(4):221-226. doi: 10.3760/cma.j.cn112141-20200302-00168.
To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID-19. We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID-19 in Renmin Hospital of Wuhan University, and proposed management strategies for patients with gynecological tumors underriskof COVID-19. Based on the national diagnosis and treatment protocol as well as research progress for COVID-19, three patients with COVID-19 were treated. Meanwhile, they were also appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19. Patients with gynecological malignant tumors are high-risk groups prone to COVID-19, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While, actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner.
探索新型冠状病毒肺炎（COVID-19）暴发流行期间妇科恶性肿瘤患者的管理策略。我们回顾性分析了武汉大学人民医院3例合并COVID-19的妇科恶性肿瘤患者的临床特征、治疗情况及疾病转归，并提出了COVID-19风险下妇科肿瘤患者的管理策略。依据国家诊疗方案及COVID-19研究进展对3例COVID-19患者进行治疗，同时参照妇科肿瘤临床指南对治疗方案进行适当调整。2例患者肺炎治愈，1例患者死于COVID-19。妇科恶性肿瘤患者是COVID-19的高危人群，妇科肿瘤医生需根据具体情况开展宣教、预防、防控及治疗工作。在积极防控COVID-19的同时，应有序、安全地开展妇科恶性肿瘤的诊治工作。
